Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Advisor operating in the Therapeutics space. If you think a Advisor is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Martin Landaluce
Strategic Advisory Board of Broadview Ventures
Martin Landaluce, a member of Broadview’s Strategic Advisory Board, has also been a member of the Fondation Leducq Board of Directors for 10 years, and serves as its treasurer. His responsibilities include the financial management of the Foundation, and the coordination of activities with the Leducq Trust, where he oversees investment and spending policies and handles the legal matters of the Trust and its underlying companies.
Follow Martin Landaluce:
About : Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Kim Fox
Strategic Advisory Board of Broadview Ventures
Kim Fox, MD, a member of Broadview’s Strategic Advisory Board, is a Consultant Cardiologist and Director of Cardiology at the Royal Brompton Hospital and Professor of Clinical Cardiology, Imperial College. Professor Fox has published over 400 papers in leading scientific journals. His expertise is in the understanding, investigation and treatment of angina; he has played a major role in many important international clinical trials (EUROPA, HPS, ASCOT etc) that have revolutionized the treatment of this condition. He is the acknowledged European expert in this field and consequently chairs the Task Force producing the European Angina Guidelines and chairs the committee responsible for the audit for the management of these patients in Europe. Professor Fox has given plenary lectures to National Societies all over the world. He has given the “Finlayson Lecture” to the Royal College of Surgeons in Glasgow, the “St Cyres Lecture” to the British Cardiac Society and the “Andrea Cissalpino Lecture” to the Italian Society of Cardiology. Professor Fox has been elected an honorary member of the French Cardiac Society and Japanese Circulation Society for his services to cardiology.
Follow Kim Fox:
About : Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Chris Jones
Non Executive Director & Special Advisor of MediSieve
Chris Jones joined Elasmogen as Executive Chairman in 2016.
Follow Chris Jones:
About Elasmogen, MediSieve, Mologic: MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Carl Sterritt
Strategic Advisor of Lunac Therapeutics
Follow Carl Sterritt:
About : Lunac Therapeutics is a UK-based drug discovery company.
Jake Arnold-Forster
Business Advisor of MIRA Rehab
Follow Jake Arnold-Forster:
About MIRA Rehab: Digital Health Company that is Gamifying Physiotherapy and Transforming Rehabilitation.
Bibhas Roy
Clinical Advisor of MIRA Rehab
Follow Bibhas Roy:
About MIRA Rehab: Digital Health Company that is Gamifying Physiotherapy and Transforming Rehabilitation.
Bibhas Roy
Clinical Advisor of MIRA Rehab
Follow Bibhas Roy:
About MIRA Rehab: Digital Health Company that is Gamifying Physiotherapy and Transforming Rehabilitation.
John Sinden
Senior Scientific Advisor of ReNeuron Group
John Sinden is the Senior Scientific Advisor of [ReNeuronGroup](https://www.crunchbase.com/organization/reneuron-group#/entity), a developer of stem cell therapies for a range of neurodegenerative diseases and other conditions. Sinden holds a bachelor’s degree in psychology from the University of Sydney and PhD in neuroscience from the University of Paris. Sinden is based in Guildford, United Kingdom.
Follow John Sinden:
About Glialign, ReNeuron Group: ReNeuron Group engages in R&D and the commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications.
